Effective June 12, 2022, the USA will no longer require pre-departure COVID-19 testing for travelers coming to the USA.
Please refer to current CDC guidelines for international air travel.
Please read carefully the information sent from the Department of State:
All J-1 exchange visitor applicants (age 18 or older at the time of travel) will be required to be fully vaccinated and to provide proof of vaccination status prior to boarding an airplane to fly to the United States.
|Vaccination Name||Approved by|
|Pfizer-BioNTech (2-dose series)||CDC/FDA, WHO|
|Moderna (2-dose series)||CDC/FDA, WHO|
|Janssen / Johnson & Johnson (single dose)||CDC/FDA, WHO|
|AstraZeneca (2-dose series)||WHO|
|Covishield (2-dose series)||WHO|
|Sinovac (2-dose series)||WHO|
|BIBP/Sinopharm (2-dose series)||WHO|
“All J applicants must present a new Form DS-2019 when applying for a visa, even if they are reapplying for the same category the following year. The Department has removed the requirement for J applicants to have the same SEVIS number in order to qualify for the 48-month interview waiver. As a result, applicants who have been issued a J visa in the past 48 months may potentially qualify for an interview waiver if they are again applying for a new J visa.
Consular resources and local government restrictions vary widely, and each consular section is continuously reviewing its capacity to adjudicate visa applications during this worldwide pandemic and as we address global issues and competing priorities. We encourage applicants to check the website of the relevant U.S. embassy or consulate to confirm the level of services currently offered and to find guidelines for applying for a J visa without an interview.”
Greenheart will update this page with information as we learn it. Greenheart follows the U.S. government regulations with regards to vaccination, thus recommends that everyone gets vaccinated when they are able to.